Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome
about
Epidemiologic and molecular prognostic review of glioblastomaParadoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study.IDH1-associated primary glioblastoma in young adults displays differential patterns of tumour and vascular morphologyQuantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma.Identification of differential splicing genes in gliomas using exon expression profiling.PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cellsPrognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation StatusPlasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.Reduced expression of microRNA‑206 regulates cell proliferation via cyclinD2 in gliomas.Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics.Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.IDH-1R132H mutation status in diffuse glioma patients: implications for classificationCodeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas.Radiological imaging features of glioblastoma with oligodendroglioma component: a comparison with conventional glioblastoma.Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution.Progress on molecular biomarkers and classification of malignant gliomas.Using the molecular classification of glioblastoma to inform personalized treatment.RAB34 was a progression- and prognosis-associated biomarker in gliomas.The impact of MGMT methylation and IDH-1 mutation on long-term outcome for glioblastoma treated with chemoradiotherapy.Expression and prognostic value of the aldehyde dehydrogenase 1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential markers in human astrocytomas.The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival.Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.Glioblastomas with oligodendroglial component have the same clinical phenotype as classical glioblastomas.Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma.Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components.Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis.Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling.IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.Glioblastoma with Both Oligodendroglioma and Primitive Neuroectodermal Tumor-Like Components in a Case with 9-Year Survival.
P2860
Q28395302-585C7857-62A6-4391-AE48-7D561C75A18BQ30984368-F90624AD-609F-4F84-A3A2-A57DF3F7AA52Q33828100-B6A1B460-8FF3-4E2C-B83A-AA7A7990EF14Q34602320-2D519D40-1745-4894-9FBD-8D3520A6783BQ34650241-724CA6DD-9DFD-4119-8EF0-B2266B1BFB3EQ34673613-1B407C87-F506-481E-9133-8D93C73815B5Q35018554-BABDDD66-8A03-4F44-B625-3C906C24ABEAQ35028828-C47ECF9C-D6F0-4D57-9CA3-FD10B3F8CC10Q35137451-2F384213-ED3D-427F-ABF3-C0A36C2DA57AQ35201676-29CAEA78-45A5-4DC7-87ED-78643311EAD3Q35894329-8201685B-DBAB-47D1-A94E-41F837CA48B0Q36457608-5E028D17-EA6E-45AD-979F-2C4927BB1BEAQ36550804-F89A143C-0928-4473-BC72-537F42DF06F5Q36904087-63B425B8-EE6C-4704-A53B-D9646933D3CFQ37327761-99CFD08C-4A76-4980-AEEC-33C059510A53Q37409721-6C82E05D-1744-47EE-A5E8-76AB5329B8CFQ37436717-B10C51A2-520C-44F3-A7A9-51F8ECC121FBQ37471678-362BBD52-6081-44E6-93FD-4AED1D5EBBC8Q38107462-2A2735CA-49AC-4813-AEA6-FEDB6905276AQ38151582-F8510385-8F9C-4E19-9F3C-5CD1443822ADQ38469088-30403022-114B-4586-9DBA-7EB864CDE69FQ39488671-1904C780-4C89-41A2-905A-8AF38558D102Q40260819-E0B757E3-86D6-4451-AEF7-E748CC9B0B1BQ41416115-57812AD2-0234-4133-82EF-3F405CC16279Q43656999-7CB5C4B1-DBC6-4459-B3DE-EEBD96C8BFF1Q43859912-744639D3-654D-461B-8976-4E881065A1D4Q44293216-4AED6BD8-23C8-43F3-8746-9246D3112D52Q44435988-3BE85E6C-A7E8-4F9F-8DC7-DE4A78AB15A6Q44517700-F7BC7A7A-850B-487F-8F69-A030B313DF0FQ45338889-A77660E4-DBBB-4AFA-BADC-5C9EB8995C4CQ48109859-CC3807F8-3A1F-4598-9945-A7E42A0E233EQ48261392-E32E40A4-1367-4146-BC06-030CCFAFD74CQ48453105-A75C2623-754B-4E50-8F13-78AA12AFEFD3Q52321854-BFADBCEA-CB27-4AA4-820D-77C2A59CCC40Q55455001-B82A389A-B648-48DC-9FD2-7EC6A20A1242Q55501452-FDA998D2-212F-4B3F-A493-F188AC57BC52
P2860
Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Glioblastoma with an oligodend ...... netic alterations, and outcome
@ast
Glioblastoma with an oligodend ...... netic alterations, and outcome
@en
type
label
Glioblastoma with an oligodend ...... netic alterations, and outcome
@ast
Glioblastoma with an oligodend ...... netic alterations, and outcome
@en
prefLabel
Glioblastoma with an oligodend ...... netic alterations, and outcome
@ast
Glioblastoma with an oligodend ...... netic alterations, and outcome
@en
P2093
P2860
P356
P1433
P1476
Glioblastoma with an oligodend ...... netic alterations, and outcome
@en
P2093
Chunsheng Kang
Lingchao Chen
Shouwei Li
Yongzhi Wang
P2860
P304
P356
10.1093/NEUONC/NOR232
P577
2012-02-10T00:00:00Z